The Supreme Court will on Friday hear the plea filed in connection with the Leprosy treatment.
A writ petition (Pankaj Sinha vs Union of India), highlighting the need to curb unfair practices against children affected by leprosy in educational institutions, was filed before the apex court in 2014.
A bench of Justices Dipak Misra and Vikramjit Sen asked the Centre and states to respond in two weeks to a PIL filed by Pankaj Sinha, who suggested that the governments set up colonies for leprosy patients, cure them and take steps to assimilate them back in society without they facing any stigma.
Appearing for the petitioner, senior advocate Colin Gonsalves said multidrug therapy (MDT) available since 1981 could cure a person of 99 percent of leprosy bacteria yet three decades later, "due to apathy of Union government and the states, people are still suffering the disease, which is treated as a social stigma.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
